Dermatologists on New Treatments for Chronic Skin Conditions

13

For anyone living with eczema, psoriasis, chronic hives or another chronic skin condition, treatment is changing fast. Newer medications can mean clearer skin with fewer injections, while targeted pills offer alternatives for people who would rather skip the needle. And someday, genetic testing could help doctors choose the right treatment without months of trial and error.

At the American Society for Dermatologic Surgery (ASDS) meeting in San Diego, four dermatologists joined our NewBeauty RX panel to discuss what’s changing in their practices and what’s coming next for patients with chronic skin conditions, including hidradenitis suppurativa (HS), vitiligo and alopecia. Providence, UT dermatologist Dr. Cory Maughan, Fort Lauderdale, FL dermatologist Dr. Matthew Elias, New York, NY dermatologist Dr. Hamza Bhatti and Anchorage, AK dermatologist Janine Miller, MD shared the advances they’re most excited about.

  • Dr. Cory Maughan is a board-certified dermatologist in Providence, UT
  • Dr. Matthew Elias is a board-certified dermatologist in Fort Lauderdale, FL
  • Dr. Hamza Bhatti is a board-certified dermatologist at Schweiger Dermatology in New York
  • Janine Miller, MD is a board-certified dermatologist in Anchorage, AK

More Options, Better Results

Not long ago, severe eczema or psoriasis came with limited treatment options and plenty of side effects. “It used to be, like, I’m so sorry. Here’s methotrexate. Here’s cyclosporine. Like, here’s these old drugs with a lot of side effects,” says Dr. Miller.

Then came biologics, injectable medications that target specific parts of the immune system driving inflammation. “For chronic skin conditions for decades, we didn’t have really wonderful treatments. We had treatments that helped but had a lot of risks,” says Dr. Elias. “And biologics have been revolutionary in that they are super safe and super effective.”

JAK inhibitors, pills and creams that block the immune signals behind inflammation, have expanded those options further for certain conditions. “When I was in training, there was such little available for people with chronic conditions, and then biologics kind of exploded,” says Dr. Maughan. JAK inhibitors, he adds, have been “a solution for a lot of conditions that we didn’t have much before.”

The difference is especially meaningful for patients with conditions like vitiligo and alopecia, who once had very few effective options. “It doesn’t mean for sure it’s going to work, but it’s safe and it’s effective,” says Dr. Miller. “It’s not like, just deal with it.”

Clearer Skin, Fewer Shots

Dr. Bhatti says the bar for treatment results has climbed considerably. Where 75 percent clearance was once the goal for psoriasis and eczema, newer therapies are approaching 90 to 95 percent in some patients. Many also require less lab monitoring than older medications.

The dosing schedules are changing, too. Dr. Elias points out that some older biologics required weekly injections, while newer treatments may be given just a few times a year. He hopes those intervals will stretch even further. “If you’re only taking something once a year or once every five years, it’s very, very, very easy for patients,” he says. “So that is truly revolutionary.”

For patients, that can mean spending less time thinking about their condition. “You’re not thinking about the disease state every day anymore,” says Dr. Bhatti.

There is one catch: Many treatments must be continued to maintain results. Dr. Miller compares some oral alopecia medications to medications for chronic conditions like heart disease. Stopping them can mean losing the progress patients have made.

What Drug Commercials Don’t Tell You

Those prescription drug commercials filling television screens have one unexpected benefit: They encourage patients to seek help.

Dr. Maughan regularly sees people who recognize a medication from an advertisement, such as the psoriasis biologic Cosentyx, and ask about it. “They’ll make an appointment to come in and be like, hey, I want to start Cosentyx,” he says. “I’m like, well, that’s not necessarily the right drug. We got to talk about a different one, but at least it brings it up.”

The problem is that commercials rarely explain enough for patients to understand whether a drug is appropriate for them. “There’s not enough information on those commercials for patients to really understand,” he says.

A dermatologist can consider the severity of a condition, previous treatments and other health concerns before recommending medication. Think of an advertisement as a conversation starter, not a treatment plan.

Pill or Shot?

Dermatology has come full circle, says Dr. Elias. Older medications were often pills, then biologics brought a wave of injectable treatments. Now newer targeted oral medications are expanding the options again.

For people with chronic hives, newer treatment options are also changing conversations about managing symptoms when antihistamines aren’t enough.

Dr. Elias puts the decision into perspective: Would you rather have an injection every few months or take a pill once or twice a day? Some patients prefer pills, while others would happily choose an occasional injection over remembering daily medication.

Of course, not every treatment is approved for every condition, and individual risks matter. But having more options means dermatologists can better match treatment to patients’ needs and preferences.

Could Genetic Testing Change Everything?

Doctors may soon match the medication to the patient from the first dose. Gene expression tests like Castle Biosciences’ AdvanceAD-Tx, which use a quick, noninvasive skin scraping, are designed to predict who will respond to which atopic dermatitis (eczema) treatment. “And then we’ll pick the right drug the first time,” says Dr. Maughan.

A cure is a taller order. “It’s really hard to go from 80 to 100 and get these drugs where they’re a cure,” says Dr. Elias. Until then, Dr. Maughan’s advice is simple: “Stay on it. Have good quality of life. And then maybe we cure it.”

If you haven’t revisited your treatment plan lately, ask your dermatologist what’s changed. For more expert advice, visit NewBeauty RX.

Close
Your custom text © Copyright 2020. All rights reserved.
Close